Unexpected, but welcome, inclusion in Cures 2.0 of provision for real-world evidence in evaluation of safety and efficacy of pharmaceutical products. CONTEXT: The follow-up to the U.S 21st Century Cures Continue Reading
CONTEXT: Commercial announcement of another pharmaceutical company securing access to RWD, in this case across oncology centres in France. IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – Continue Reading
CONTEXT: FDA publishing an action plan on AI in SAAMDs. China already ahead of the game in terms of how they have already enacted guidance on AI in SAAMDs, but Continue Reading
CONTEXT: FDA publishing an action plan on AI in SAAMDs. China already ahead of the game in terms of how they have already enacted guidance on AI in SAAMDs, but Continue Reading
